English-Spanish translation for "lupus anticoagulant"

lupus anticoagulant {noun} [med.]

     lupus

     anticoagulant

To assess the effects of drugs for discoid lupus erythematosus.

The study tested 32 people who had central nervous system lupus.

We included all randomised trials of drugs to treat people with discoid lupus erythematosus.

Does cyclophosphamide work to treat central nervous system lupus (neuropsychiatric lupus)?

Systemic lupus erythematosus (SLE) is a chronic inflammatory, multisystem autoimmune condition.

There is not enough reliable evidence about other drugs used to treat discoid lupus erythematosus.

In CNS lupus (central nervous system lupus) the body may have attacked and damaged the cells in the brain and spine.

A substance as toxic as heparin, a rat poison, turns out to be an effective anticoagulant which has saved many lives.

The risk of extracranial bleeding was higher with anticoagulant therapy than with antiplatelet therapy.

Intracranial hemorrhages (OR 1.98, 95% CI 1.20 to 3.28) were increased by oral anticoagulant therapy.

that cyclophosphamide may improve symptoms of central nervous system (neuropsychiatric) lupus more than methylprednisolone.

Fluocinonide cream may be more effective than hydrocortisone in treating people with discoid lupus erythematosus.

The acitretin trial was flawed by the inclusion of people with subacute cutaneous lupus and by the lack of a placebo arm.

Discoid lupus erythematosus is a chronic form of cutaneous (skin) lupus which can cause permanent scarring if treatment is inadequate.

Drugs such as corticosteroids (prednisone or methylprednisolone) are usually used for lupus to decrease inflammation and control the immune system.

To assess the effectiveness and safety of dehydroepiandrosterone compared to placebo in the treatment of people with systemic lupus erythematosus.

However, anticoagulant drugs may also cause bleeding in the brain and this complication could offset any benefits.

In patients with acute ischaemic stroke, immediate anticoagulant therapy is not associated with net short or long-term benefit.